Italy· 047789019
DOTECINE*12 cpr 200 mg rilascio modificato
A rifamycin product containing rifamicina, registered in Italy by MALESCI SpA IST.FARMACOBIOL., on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Rifamicina
- Manufacturer
- MALESCI SpA IST.FARMACOBIOL.
- Country
- Italy (IT)
- ATC code
- S02AA12
- ATC class
- Rifamycin
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic047789019DOTECINE*12 cpr 200 mg rilascio modificatoEUR 8.32
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifamycin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceOTOFA, solution auriculaire en gouttesBOUCHARA-RECORDATI
- GermanyGutiviaLunatus Gmbh
- SpainRIFAMICINA ADALVO 200 MG COMPRIMIDOS DE LIBERACION MODIFICADAAdalvo Competence Center S.R.L.
- FinlandRelafalkAdalvo Competence Center S.R.L.
- PolandRifamycin AdalvoAdalvo Competence Center S.R.L.
- BelgiumRifocine 500 IV 500 mgSanofi Belgium
- SwedenRifamycin Adalvo 200 mg Tablett med modifierad frisättningAdalvo Limited
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Rifocine I.V.
- Bulgaria · Relafalk
- Germany · Gutivia
- Finland · Relafalk
- France · Otofa, Rifamycine Chibret
- Greece · Relafalk
- Hungary · Relafalk
- Luxembourg · Otofa, Rifocine I.V.
- Norway · Relafalk
- Poland · Relafalk
- Portugal · Imfalda, Rifocina
- Sweden · Relafalk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2ef816e-8ae2-4743-b5d9-a4bf531e0d82 GET /v1/drugs/d2ef816e-8ae2-4743-b5d9-a4bf531e0d82?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 8.32,
"source": "aifa",
"currency": "EUR",
"strength": "RIFAMICINA 200MG 12 UNITA' USO ORALE RM",
"substance": "Rifamicina",
"equivalence_group": "MMZ",
"transparency_flag": null
}See everything about rifamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.